Dopexamine: Difference between revisions

Jump to navigation Jump to search
m (Protected "Dopexamine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Line 27: Line 27:
{{CMG}}
{{CMG}}


{{Editor Join}}
 


==Overview==
==Overview==
Line 36: Line 36:
[[Category:Phenethylamines]]
[[Category:Phenethylamines]]
[[Category:Drugs]]
[[Category:Drugs]]
{{SIB}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}

Revision as of 00:52, 9 August 2012

Dopexamine
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC22H32N2O2
Molar mass429.43 g/mol

WikiDoc Resources for Dopexamine

Articles

Most recent articles on Dopexamine

Most cited articles on Dopexamine

Review articles on Dopexamine

Articles on Dopexamine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Dopexamine

Images of Dopexamine

Photos of Dopexamine

Podcasts & MP3s on Dopexamine

Videos on Dopexamine

Evidence Based Medicine

Cochrane Collaboration on Dopexamine

Bandolier on Dopexamine

TRIP on Dopexamine

Clinical Trials

Ongoing Trials on Dopexamine at Clinical Trials.gov

Trial results on Dopexamine

Clinical Trials on Dopexamine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Dopexamine

NICE Guidance on Dopexamine

NHS PRODIGY Guidance

FDA on Dopexamine

CDC on Dopexamine

Books

Books on Dopexamine

News

Dopexamine in the news

Be alerted to news on Dopexamine

News trends on Dopexamine

Commentary

Blogs on Dopexamine

Definitions

Definitions of Dopexamine

Patient Resources / Community

Patient resources on Dopexamine

Discussion groups on Dopexamine

Patient Handouts on Dopexamine

Directions to Hospitals Treating Dopexamine

Risk calculators and risk factors for Dopexamine

Healthcare Provider Resources

Symptoms of Dopexamine

Causes & Risk Factors for Dopexamine

Diagnostic studies for Dopexamine

Treatment of Dopexamine

Continuing Medical Education (CME)

CME Programs on Dopexamine

International

Dopexamine en Espanol

Dopexamine en Francais

Business

Dopexamine in the Marketplace

Patents on Dopexamine

Experimental / Informatics

List of terms related to Dopexamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Dopexamine is a β2-adrenergic receptor agonist.


Template:WikiDoc Sources